| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |